BioMarin Pharmaceutical | Capital Social E Reservas



Equity Capital And Reserves Alterar Data
Acadia Pharmaceuticals USD 822.38M 57.14M 2025-06
Agios Pharmaceuticals USD 1.37B 96.97M 2025-06
Alnylam Pharmaceuticals USD 250.59M 135.16M 2025-06
Amgen USD 7.43B 1.22B 2025-06
Bayer EUR 30.5B 2.08B 2025-06
Biogen USD 17.63B 655.3M 2025-06
BioMarin Pharmaceutical USD 6.03B 233.65M 2025-06
Gilead Sciences USD 19.67B 596M 2025-06
Incyte USD 4.17B 503.34M 2025-06
Insmed USD 1.25B 1.15B 2025-06
Ionis Pharmaceuticals USD 631.72M 156M 2025-06
Moderna USD 9.4B 667M 2025-06
Neurocrine Biosciences USD 2.69B 158.6M 2025-06
PTC Therapeutics USD -206546000 20.79M 2025-06
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 77.86B 4.86B 2024-12
Sarepta Therapeutics USD 1.36B 214.66M 2025-06
Ultragenyx Pharmaceutical USD 151.29M 7.04M 2025-06
United Therapeutics USD 7.17B 366.4M 2025-06
Vertex Pharmaceuticals USD 17.18B 679.1M 2025-06


BioMarin Pharmaceutical Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.